Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 3 - Precision medicine for Head and Neck cancer

Treatment specificities of Human Papillomavirus (HPV)-induced oropharyngeal cancer: - The surgeon’s point of view- The radiation oncologist’s point of view

Date

24 Sep 2022

Session

Session 3 - Precision medicine for Head and Neck cancer

Topics

Radiation Oncology;  Surgical Oncology

Tumour Site

Head and Neck Cancers

Presenters

Christian Simon, CH Sandra Nuyts, BE

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.